Quarterly report pursuant to Section 13 or 15(d)

Note 10 - Shareholders' Equity

v3.22.2
Note 10 - Shareholders' Equity
 6 Months Ended
Jun. 30, 2022
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]

10.

Shareholders’ Equity

 

Authorized capital stock

 

The Company has authorized share capital of an unlimited number of voting common shares and the shares do not have a stated par value.

 

Common shareholders are entitled to receive dividends as declared by the Company, if any, and are entitled to one vote per share at the Company's annual general meeting and any special meeting.

 

 

Equity issued during the six months ended June 30, 2022

 

During the six months ended June 30, 2022, we did not issue any common shares.

 

Equity issued during the six months ended June 30, 2021

 

During the six months ended June 30, 2021, 40,000 common shares were issued upon the exercise of options for gross proceeds of $244,000 with an aggregate intrinsic value of $132,000 and no warrants were exercised.

 

Shares reserved

 

Common shares reserved for future issuance are as follows:

   

June 30, 2022

  

Common shares issuable upon exercise of employee and non-employee stock options

     2,623,998  

Common shares issuable upon settlement of deferred stock units

     134,402  

Common shares issuable upon exercise of common share purchase warrants

     265,000  

Shares available for grant under the 2019 Omnibus Incentive Plan

     2,026,010  

Shares available for grant under the 2021 Employment Inducement Incentive Plan

     675,000  

Total

     5,724,410